Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | FETZIMA® (levomilnacipran) ER Capsules | HCP Official |
Description | Imagine taking a step with Choose FETZIMA® as a treatment for your appropriate adult MDD patients. See safety info, including Boxed Warning & full Prescribing |
Keywords | N/A |
WebSite | fetzimahcp.com |
Host IP | 72.52.10.14 |
Location | United States |
Site | Rank |
US$5,212,754
Last updated: 2023-05-09 14:07:40
fetzimahcp.com has Semrush global rank of 2,030,463. fetzimahcp.com has an estimated worth of US$ 5,212,754, based on its estimated Ads revenue. fetzimahcp.com receives approximately 601,472 unique visitors each day. Its web server is located in United States, with IP address 72.52.10.14. According to SiteAdvisor, fetzimahcp.com is safe to visit. |
Purchase/Sale Value | US$5,212,754 |
Daily Ads Revenue | US$4,812 |
Monthly Ads Revenue | US$144,354 |
Yearly Ads Revenue | US$1,732,239 |
Daily Unique Visitors | 40,099 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
fetzimahcp.com. | A | 299 | IP: 72.52.10.14 |
fetzimahcp.com. | NS | 86400 | NS Record: ha1.markmonitor.zone. |
fetzimahcp.com. | NS | 86400 | NS Record: ha2.markmonitor.zone. |
fetzimahcp.com. | NS | 86400 | NS Record: ha3.markmonitor.zone. |
fetzimahcp.com. | NS | 86400 | NS Record: ha4.markmonitor.zone. |
fetzimahcp.com. | MX | 14400 | MX Record: 10 mxa-0015e701.gslb.pphosted.com. |
fetzimahcp.com. | MX | 14400 | MX Record: 10 mxb-0015e701.gslb.pphosted.com. |
fetzimahcp.com. | TXT | 3600 | TXT Record: v=spf1 mx include:spf-0015e701.pphosted.com ~all |
fetzimahcp.com. | TXT | 3600 | TXT Record: 9b5764ac71cc4b50ac8f4e1fcdee721c |
This site is intended for U.S. healthcare professionals only. Request Samples: Online | Print Prescribing Information | Visit Patient Site This site is intended for U.S. healthcare professionals only. Request Samples: Online | Print About MDD Efficacy Efficacy MADRS & SDS Scales Patient Characteristics Clinical Study Results Adverse Event Profile Adverse Event Profile Adverse Reactions Dose-Related Adverse Reactions Effect on Body Weight 1-Year, Open-Label Study Dosing Mechanism of Action Resources Resources Patient Profiles Savings Depression can disrupt your patients’ lives. Imagine taking a step with FETZIMA ® . FETZIMA is FDA-approved for the treatment of Major Depressive Disorder (MDD) in adults.* Learn More *FETZIMA is not approved for the management of fibromyalgia, and its efficacy and safety have not been established for that use. Impact on Depressive Symptoms See how FETZIMA patients achieved significant improvement in depressive symptoms across 3 dosage strengths. 1-4 See |
HTTP/1.1 301 Moved Permanently cache-control: no-cache, no-store, must-revalidate Pragma: no-cache Expires: -1 X-XSS-Protection: 1; mode=block X-Content-Type-Options: nosniff X-Frame-Options: DENY Content-Security-Policy: script-src 'self' Location: http://www.fetzimahcp.com/ Vary: Accept Content-Type: text/plain; charset=utf-8 Content-Length: 60 Date: Sun, 31 Oct 2021 23:52:23 GMT Connection: keep-alive Set-Cookie: NSC_us_nbsl-83+63+21+25-91=ffffffff2fe62ef045525d5f4f58455e445a4a423660;path=/;httponly HTTP/1.1 301 Moved Permanently Content-Type: text/html Content-Length: 20 Connection: keep-alive Date: Sun, 31 Oct 2021 23:51:42 GMT Location: https://www.fetzimahcp.com/ Server: Microsoft-IIS/8.5 X-Cache: Miss from cloudfront Via: 1.1 f43d3fd3b180d6990058c868e5ed1d0c.cloudfront.net (CloudFront) X-Amz-Cf-Pop: MSP50-C1 X-Amz-Cf-Id: _YUtxBgxX4ReVB9C-UQJtcK_cgv3HKGrcHkDcQGkhDW0lthqFeLIQg== HTTP/1.1 200 OK Content-Type: text/html; charset=utf-8 Content-Length: 49174 Connection: keep-alive Date: Sun, 31 Oct 2021 23:51:42 GMT Cache-Control: private X-AspNetMvc-Version: 5.2 X-AspNet-Version: 4.0.30319 X-Powered-By: ASP.NET Strict-Transport-Security: max-age=31536000 Set-Cookie: _plbsid_600=1; path=/; HttpOnly Server: Microsoft-IIS/8.5 Vary: Accept-Encoding,Accept-Encoding X-Cache: Miss from cloudfront Via: 1.1 5d23f86132595aa6fb73880c63f21745.cloudfront.net (CloudFront) X-Amz-Cf-Pop: MSP50-C1 X-Amz-Cf-Id: ePXYf8b1XzaC0ac8JOM5u5vKmSMoWSC0k8zvp_o8WNk2fDg10S4c5w== |
Domain Name: FETZIMAHCP.COM Registry Domain ID: 1820335056_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2021-03-04T04:34:11Z Creation Date: 2013-08-07T09:02:07Z Registry Expiry Date: 2022-08-07T09:02:07Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: HA1.MARKMONITOR.ZONE Name Server: HA2.MARKMONITOR.ZONE Name Server: HA3.MARKMONITOR.ZONE Name Server: HA4.MARKMONITOR.ZONE DNSSEC: unsigned >>> Last update of whois database: 2021-09-19T09:38:50Z <<< |